Two Sigma Securities’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.58K Sell
10,000
-67,350
-87% -$41.5K ﹤0.01% 1508
2025
Q4
$60.6K Buy
+77,350
New +$56.2K 0.01% 1045
2025
Q1
Sell
-23,126
Closed -$10.2K 2312
2024
Q4
$10.2K Sell
23,126
-976
-4% -$473 ﹤0.01% 1433
2024
Q3
$16.3K Buy
+24,102
New +$15.9K ﹤0.01% 2529
2023
Q3
Sell
-25,238
Closed -$23.5K 3565
2023
Q2
$23.5K Buy
25,238
+9,118
+57% +$6.08K ﹤0.01% 2485
2023
Q1
$10.3K Buy
+16,120
New +$11.8K ﹤0.01% 2451
2022
Q1
Sell
-22,958
Closed -$13K 2585
2021
Q4
$13K Buy
+22,958
New +$21.6K ﹤0.01% 1456

Other funds holding XTNT

Two Sigma Securities's XTNT Position: Q1 2026 in Review

Two Sigma Securities reduced its Xtant Medical Holdings (XTNT) stake by 87% in Q1 2026, selling an estimated $41.5K and leaving 10,000 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Two Sigma Securities first reported a position in XTNT in Q4 2021 and has held it in 7 quarters since. The position peaked at $60.6K in Q4 2025. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Two Sigma Securities held 10,000 shares of Xtant Medical Holdings worth $5.58K as of Q1 2026.
  • Two Sigma Securities sold 67,350 Xtant Medical Holdings shares in Q1 2026, an estimated $41.5K.
  • Xtant Medical Holdings made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1508 holding.
  • Two Sigma Securities first reported a position in Xtant Medical Holdings in Q4 2021 and has held it in 7 quarters since.
  • Two Sigma Securities's Xtant Medical Holdings position peaked at $60.6K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.